Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Il y a eu 49 transactions d'initiés récentes enregistrées pour Vallon Pharmaceuticals, Inc. (VLON), dont 30 achats et 8 ventes. Le total des achats d'initiés s'élève à $3M et le total des ventes d'initiés à $254.48K.

Les initiés notables ayant une activité récente comprennent Kelly Leanne, Szekeres David Leslie, Rongen Roelof. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — VLON

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-09-22	Kelly Leanne	Chief Financial Officer	Attribution de RSU	83,333	$1.52	$126.67K	83,333
2023-08-10	Szekeres David Leslie	Director	Attribution de RSU	34,483	$2.90	$100K	34,483
2023-08-10	Rongen Roelof	Director	Attribution de RSU	34,483	$2.90	$100K	34,483
2023-08-10	Simpson Camilla V	Director	Attribution de RSU	34,483	$2.90	$100K	34,483
2023-08-10	Baker David Charles	Director	Attribution de RSU	34,483	$2.90	$100K	34,483
2023-04-21	Szekeres David Leslie	Director	Inconnu	-	-	-	-
2023-04-21	Agro Albert	Chief Medical Officer	Attribution de RSU	172,189	-	-	172,189
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	Attribution de RSU	385,510	-	-	385,510
2023-04-21	Chaturvedi Vipin	Chief Scientific Officer	Attribution de RSU	172,189	-	-	172,189
2023-04-21	Agro Albert	Officer	Inconnu	-	-	-	-
2023-04-21	Rongen Roelof	Director	Inconnu	-	-	-	-
2023-04-21	Simpson Camilla V	Director	Inconnu	-	-	-	-
2023-04-21	Hertz Walter Marc	10 Percent Owner, Officer: Chief Executive Officer	Inconnu	-	-	-	-
2023-04-21	Chaturvedi Vipin	Officer	Inconnu	-	-	-	-
2022-12-13	Thorell Marella	Director	Autre (Vente)	28,517	-	-	9,506
2022-07-01	Thorell Marella	Director	Attribution de RSU	38,023	-	-	38,023
2022-06-09	Payne Joseph E	Director	Attribution de RSU	7,500	-	-	7,500
2022-06-09	Thorell Marella	Director	Attribution de RSU	7,500	$0.51	$3.83K	7,500
2022-06-09	Ammer Richard	Director	Attribution de RSU	7,500	-	-	7,500
2022-02-23	Chhabra Meenu	Director	Inconnu	-	-	-	-
2022-02-23	Chhabra Meenu	Director	Attribution de RSU	15,000	$7.67	$115.05K	15,000
2022-02-15	Kelly Leanne M.	Chief Financial Officer	Attribution de RSU	50,000	$5.63	$281.5K	50,000
2022-02-15	Baker David Charles	Chief Executive Officer	Attribution de RSU	61,000	$5.63	$343.43K	61,000
2021-06-04	Kelly Leanne M.	Chief Financial Officer	Achat Informatif	1,508	$4.08	$6.15K	6,250
2021-06-03	Kelly Leanne M.	Chief Financial Officer	Achat Informatif	1,085	$4.05	$4.39K	4,742
2021-06-02	Kelly Leanne M.	Chief Financial Officer	Achat Informatif	3,657	$4.00	$14.63K	3,657
2021-05-26	Payne Joseph E	Director	Achat Informatif	6,800	$4.50	$30.6K	17,500
2021-05-25	Payne Joseph E	Director	Achat Informatif	10,700	$3.85	$41.2K	10,700
2021-05-14	Kelly Leanne M.	Chief Financial Officer	Attribution de RSU	70,000	$3.66	$256.2K	70,000
2021-05-14	Payne Joseph E	Director	Attribution de RSU	14,286	$3.66	$52.29K	14,286
2021-05-14	Toren Penny	SVP, Regul Affairs & Prog Mgmt	Attribution de RSU	25,000	$3.66	$91.5K	25,000
2021-05-14	Levi Ofir	Director	Attribution de RSU	15,000	$3.66	$54.9K	15,000
2021-05-14	Ammer Richard	Director	Attribution de RSU	10,204	$3.66	$37.35K	10,204
2021-05-14	Baker David Charles	Chief Executive Officer	Attribution de RSU	100,000	$3.66	$366K	100,000
2021-05-11	Kelly Leanne M.	Officer	Inconnu	-	-	-	-
2021-02-12	Thorell Marella	Director	Attribution de RSU	15,000	$8.00	$120K	15,000
2021-02-12	Ammer Richard	Director	Autre (Achat)	47,063	$6.40	$301.2K	47,063
2021-02-12	Salmon Pharma Gmbh	10 Percent Owner	Autre (Achat)	47,063	$6.40	$301.2K	47,063
2021-02-12	Baker David Charles	Chief Executive Officer	Autre (Achat)	7,843	$6.40	$50.2K	7,843
2021-02-09	Thorell Marella	Director	Inconnu	-	-	-	-
2021-02-09	Toren Penny	SVP, Regul Affairs & Prog Mgmt	Cession	5,000	$3.82	$19.1K	-
2021-02-09	Levi Ofir	Director	Cession	-	-	-	196,875
2021-02-09	Ammer Richard	10 Percent Owner	Inconnu	-	-	-	1,476,734
2021-02-09	Salmon Pharma Gmbh	10 Percent Owner	Cession	-	-	-	1,476,734
2021-02-09	Payne Joseph E	10 Percent Owner	Inconnu	-	-	-	843,750
2021-02-09	Arcturus Therapeutics Holdings Inc.	10 Percent Owner	Cession	-	-	-	843,750
2021-02-04	Baker David Charles	Chief Executive Officer	Cession	61,250	$2.20	$134.75K	-
2019-01-15	Baker David Charles	Chief Executive Officer	Cession	46,875	$1.84	$86.25K	-
2018-10-01	Toren Penny	SVP, Regul Affairs & Prog Mgmt	Cession	7,813	$1.84	$14.38K	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration